Wearable sweat sensor for critically ill patients
Part of Infections clinical trials.
This trial tests a wearable sweat sensor to monitor lactate levels in critically ill patients. It may help doctors track your condition more easily and comfortably.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are in the surgical intensive care unit (ICU).
- Your blood lactate level is higher than 1.5 mmol/L.
- You are at least 16 years old.
- You are willing to donate samples and sign a consent form.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study uses special sensor devices worn on your skin to detect early warning signs of sepsis (a dangerous blood infection). By catching sepsis earlier, doctors may be able to treat it faster and help you recover better.
This study measures how quickly a blood marker called lactate rises or falls in people with septic shock. It may help doctors understand which patterns are linked to recovery and guide better treatment decisions.
This study uses a wearable skin patch placed on you during a sepsis hospital stay to help predict whether you might need to be readmitted after discharge. It may help doctors identify who is at higher risk of rehospitalization and plan follow-up care earlier.
This trial is looking for patients who have an infection and are showing early signs of getting sicker, like a high warning score. It aims to find out if doctors can identify those at risk of sepsis sooner so they can start treatment earlier.
This trial is building a tool to predict sepsis, a life-threatening response to infection, in intensive care patients. It may help doctors act faster to prevent complications.
This trial is testing whether a new, highly sensitive blood test (droplet digital PCR) combined with genetic analysis can help doctors predict sepsis earlier in emergency room patients. This could lead to faster treatment and better outcomes.
Hear when a new Sepsis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.